Metabolite identification of small interfering RNA duplex by high-resolution accurate mass spectrometry.

On-line liquid chromatography/electrospray ionization high-resolution mass spectrometry (LC/ESI-HRMS) using an LTQ-Orbitrap mass spectrometer was employed to investigate the metabolite profiles of a model siRNA duplex designated HBV263. The HBV263 duplex was incubated in rat and human serum and liver microsomes in vitro. The siRNA drug and its metabolites were then extracted using a liquid-liquid extraction followed by solid-phase extraction (LLE-SPE), and analyzed by LC/ESI-MS. High-resolution accurate mass data enabled differentiation between two possible metabolite sequences with a monoisotopic molecular mass difference of less than 1 Da. ProMass deconvolution software was used to provide semi-automated data processing. In vitro serum and liver microsome incubation samples afforded different metabolite patterns: the antisense strand of the duplex was degraded preferentially in rat and human serum, while the sense strand of the duplex was less stable in rat and human liver microsomes.

[1]  G. Dai,et al.  Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides. , 2007, Journal of pharmaceutical and biomedical analysis.

[2]  Judy Lieberman,et al.  Interfering with disease: a progress report on siRNA-based therapeutics , 2007, Nature Reviews Drug Discovery.

[3]  A. Aigner.  Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo , 2007, Applied Microbiology and Biotechnology.

[4]  Jian Lin,et al.  Strategies for bioanalysis of an oligonucleotide class macromolecule from rat plasma using liquid chromatography-tandem mass spectrometry. , 2007, Analytical chemistry.

[5]  John J. Rossi,et al.  Strategies for silencing human disease using RNA interference , 2007, Nature Reviews Genetics.

[6]  C. Chakraborty.  Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing. , 2007, Current drug targets.

[7]  Anthony D. Keefe,et al.  Building oligonucleotide therapeutics using non-natural chemistries. , 2006, Current opinion in chemical biology.

[8]  Jennifer A. Lockridge,et al.  Liquid chromatography electrospray ionization mass spectrometry analysis of the ocular metabolites from a short interfering RNA duplex. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  B. Thomas,et al.  Mass spectrometry of RNA. , 2006, Trends in biochemical sciences.

[10]  S. Zeuzem,et al.  Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum. , 2006, Biochemical pharmacology.

[11]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[12]  Kim Hartsough,et al.  Liquid chromatography/electrospray mass spectrometric analysis of metabolites from an inhibitory RNA duplex. , 2005, Rapid communications in mass spectrometry : RCM.

[13]  B. Polisky,et al.  Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication , 2005, Hepatology.

[14]  R. Griffey,et al.  Positional effect of chemical modifications on short interference RNA activity in mammalian cells. , 2005, Journal of medicinal chemistry.

[15]  S. Hofstadler,et al.  Analysis of nucleic acids by FTICR MS. , 2005, Mass spectrometry reviews.

[16]  Erik J. Sontheimer,et al.  Assembly and function of RNA silencing complexes , 2005, Nature Reviews Molecular Cell Biology.

[17]  R. Griffey,et al.  Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. , 2005, Journal of medicinal chemistry.

[18]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[19]  J. Gebler,et al.  Electrospray ionization mass spectrometric analysis of nucleic acids using high-throughput on-line desalting. , 2004, Rapid communications in mass spectrometry : RCM.

[20]  D. Muddiman,et al.  Utility of accurate monoisotopic mass measurements to confidently identify lambda exonuclease generated single-stranded amplicons containing 7-deaza analogs by electrospray ionization FT-ICR mass spectrometry , 2004 .

[21]  David R Corey,et al.  RNA interference in mammalian cells by chemically-modified RNA. , 2003, Biochemistry.

[22]  J. Gebler,et al.  Analysis of native and chemically modified oligonucleotides by tandem ion-pair reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.

[23]  John M Koomen,et al.  Accurate mass measurement of DNA oligonucleotide ions using high-resolution time-of-flight mass spectrometry. , 2002, Journal of mass spectrometry : JMS.

[24]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[25]  W. Hancock,et al.  New procedure for the use of high-performance liquid chromatography–electrospray ionization mass spectrometry for the analysis of nucleotides and oligonucleotides , 1997 .

[26]  W S Hancock,et al.  Analysis of Oligonucleotides by HPLC-Electrospray Ionization Mass Spectrometry. , 1997, Analytical chemistry.

[27]  R. Griffey,et al.  Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer , 1997 .

[28]  L. Cummins,et al.  On-line HPLC electrospray mass spectrometry of phosphorothioate oligonucleotide metabolites. , 1997, Analytical chemistry.

[29]  J. Shaw,et al.  Modified deoxyoligonucleotides stable to exonuclease degradation in serum. , 1991, Nucleic acids research.

[30]  G. Marcucci,et al.  Metabolism of GTI-2040, a phosphorothioate oligonucleotide antisense, using ion-pair reversed phase high performance liquid chromatography (HPLC) coupled with electrospray ion-trap mass spectrometry , 2008, The AAPS Journal.

[31]  Simon W. Jones,et al.  MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity. , 2007, Molecular bioSystems.

[32]  K. Alexander,et al.  RNA interference using boranophosphate siRNAs: structure-activity relationships. , 2004, Nucleic acids research.

[33]  J. Gebler,et al.  Characterization of therapeutic oligonucleotides using liquid chromatography with on-line mass spectrometry detection. , 2003, Oligonucleotides.

[34]  C. Huber,et al.  Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry. , 2001, Mass spectrometry reviews.

[35]  D. Tolson,et al.  Sequencing RNA by a combination of exonuclease digestion and uridine specific chemical cleavage using MALDI-TOF. , 1998, Nucleic acids research.

[36]  P. Limbach.  Indirect mass spectrometric methods for characterizing and sequencing oligonucleotides. , 1996, Mass spectrometry reviews.

[37]  P. Reich,et al.  [Letters to nature] , 1975, Nature.